Y, W., J, L., M, L., R, G., S, L., Q, H., . . . L, L. (2026). Exploring the interconnection between PANoptosis and chronic inflammatory diseases: Identifying key targets and therapeutic strategies for periodontitis and ulcerative colitis. Naunyn-Schmiedeberg's archives of pharmacology, 399(1), 255. https://doi.org/10.1007/s00210-025-04320-7
Chicago Style (17th ed.) CitationY, Wu, Li J, Liu M, Gao R, Li S, Hu Q, Xie Y, and Li L. "Exploring the Interconnection Between PANoptosis and Chronic Inflammatory Diseases: Identifying Key Targets and Therapeutic Strategies for Periodontitis and Ulcerative Colitis." Naunyn-Schmiedeberg's Archives of Pharmacology 399, no. 1 (2026): 255. https://doi.org/10.1007/s00210-025-04320-7.
MLA (9th ed.) CitationY, Wu, et al. "Exploring the Interconnection Between PANoptosis and Chronic Inflammatory Diseases: Identifying Key Targets and Therapeutic Strategies for Periodontitis and Ulcerative Colitis." Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 399, no. 1, 2026, p. 255, https://doi.org/10.1007/s00210-025-04320-7.